Marley Health announced its launch as a clinical intelligence company applying human healthcare science to pet health.
The company is developing AI-enabled pet-health intelligence designed to support more proactive and data-informed veterinary care. Marley is adapting machine learning, signal processing, biomarker development, and physiological measurement methods from human healthcare for use in veterinary medicine.
Marley’s approach is built on machine-learning expertise from the University of Oxford and clinical studies conducted with veterinary patients at the Royal Veterinary College. The company’s platform is designed to translate complex animal health signals into clinically grounded insights for veterinarians and pet owners.
Marley said the pet health technology market is moving beyond location tracking and activity scores toward broader health, behavior, and disease-related insights. But the company said evidence standards across the category remain uneven, creating a need for pet-health intelligence that is validated, benchmarked, reviewed by veterinarians, and built around clinical usefulness.
The company’s first product will combine a purpose-built smart collar with digital platforms for veterinarians and pet owners. The collar will collect health-related data that supports Marley’s broader clinical intelligence layer.
The platform is being developed to establish and track pet-health biomarkers such as gait, posture, resting heart rate, and respiratory rate. Marley plans to expand into more advanced indicators over time, including signals that are common in human health but still emerging in veterinary medicine.
For veterinarians, Marley is designed to make clinically relevant changes easier to identify and track over time. The platform will provide context on a pet’s health status against clinical benchmarks, with insights developed using clinical input from the Royal Veterinary College.
For pet owners, Marley is intended to help clarify when something may be changing, how to manage a pet’s health, and when a veterinary conversation may be needed.
Marley is preparing to pilot the platform with veterinary organizations in the U.K. The early deployments will focus on refining clinical workflows, the pet-owner experience, and the validation process behind the company’s biomarker development.
As Marley’s dataset expands, the company plans to move from initial biomarker work into more sophisticated indicators and eventually clinical decision-support capabilities grounded in Royal Veterinary College validation and Oxford machine-learning expertise.
Marley Health was founded by leaders from Johnson & Johnson, the Royal Veterinary College, and Oxford’s clinical machine learning community.
KEY QUOTES:
“Veterinarians do not need more data for its own sake. They need information that is accurate, clinically relevant, and capable of helping them understand what is happening with the animal in front of them. That is the standard Marley is building toward. Pet health technology has enormous potential, but it will only earn a meaningful place in veterinary care if the science is rigorous, the data is validated, and the insights are useful in real-world clinical decision-making.”
Dr. Amanda Boag, Co-Founder and Chief Medical Officer of Marley Health
“Clinically useful AI starts with a clear understanding of the question being asked, the signal being measured, and the standard it is being measured against. Marley is applying that discipline to pet health by combining continuous data from daily life with carefully collected animal data and clinical reference points. That approach can help identify patterns that are meaningful for the individual animal and turn longitudinal measurement into insight that veterinarians can use.”
David Clifton, Co-Founder and Technology Advisor at Marley Health and Royal Academy of Engineering Chair Professor of Clinical Machine Learning at the University of Oxford
“Marley was founded on the belief that pet care can benefit from the same scientific and technological advances that have changed what is possible in human health. The goal is to build a company that helps veterinarians and owners understand pet health with more objectivity, more context, and more confidence over time. That starts with validated biomarkers, but the larger opportunity is creating the clinical intelligence layer that allows pet care to become more proactive, more precise, and more connected to what is happening in an animal’s day-to-day life.”
Nate Notwell, Co-Founder and CEO of Marley Health
